3,4-dimethoxyphenylacetamide,
2-(3,4-Dimethoxyphenyl)acetamide,
3,4-Dimethoxyphenylacetamide,
5663-56-9,
Benzeneacetamide, 3,4-dimethoxy-,
3,4-Dimethoxybenzeneacetamide,
EINECS 227-119-2,
UNII-X4OBB6GM5O,
NSC 73172,
X4OBB6GM5O,
2-(3,4-Dimethoxy-phenyl)-acetamide,
BRN 2647747,
CUWOZWFDSYIYHL-UHFFFAOYSA-N,
Acetamide, 2-(3,4-dimethoxyphenyl)- (6CI,8CI),
homoveratramide,
AC1Q46TE,
AC1Q5J6R,
Cambridge id 5110248,
NCIOpen2_000598,
Oprea1_001985,
CBDivE_003020,
Benzeneacetamide,4-dimethoxy-,
Dimethoxyphenylacetamide,3,4-,
AC1L2Y23,
SCHEMBL1033641,
(3,4-Dimethoxyphenyl)acetamide,
CHEMBL1979926,
DTXSID30205203,
DIMETHOXYPHENYLACETAMIDE,4-,
HMS1577E08,
ZINC300830,
2-(3,4-dimethoxyphenyl)-acetamide,
CS-M0062,
NSC73172,
3219AH,
CD-912,
MFCD00017141,
NSC-73172,
2-(3,4-Dimethoxyphenyl)acetamide #,
AKOS008937734,
MCULE-2374637580,
NE45473,
KS-00001E03,
3,4-dimethoxyphenylacetamide, AldrichCPR,
AJ-19071,
AS-37774,
LS-28522,
NCI60_041597,
ZB010307,
FT-0727232,
EN300-68800,
Z33546771,
C10H13NO3,
CID79746,
AR-1E9248,
C10-H13-N-O3,
4-10-00-01509 (Beilstein Handbook Reference),
5827-72-5,